Bahl & Gaynor Inc. Purchases 153,054 Shares of U.S. Physical Therapy, Inc. $USPH

Bahl & Gaynor Inc. lifted its position in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 47.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 474,688 shares of the company’s stock after purchasing an additional 153,054 shares during the quarter. Bahl & Gaynor Inc. owned 3.12% of U.S. Physical Therapy worth $40,325,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in USPH. EverSource Wealth Advisors LLC increased its position in shares of U.S. Physical Therapy by 68.8% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock valued at $40,000 after buying an additional 192 shares in the last quarter. Assetmark Inc. grew its stake in U.S. Physical Therapy by 35.7% in the second quarter. Assetmark Inc. now owns 570 shares of the company’s stock valued at $45,000 after acquiring an additional 150 shares during the period. Huntington National Bank grew its stake in U.S. Physical Therapy by 71.9% in the second quarter. Huntington National Bank now owns 667 shares of the company’s stock valued at $52,000 after acquiring an additional 279 shares during the period. Blue Trust Inc. increased its holdings in shares of U.S. Physical Therapy by 35.3% in the third quarter. Blue Trust Inc. now owns 640 shares of the company’s stock worth $54,000 after acquiring an additional 167 shares in the last quarter. Finally, Fifth Third Bancorp increased its holdings in shares of U.S. Physical Therapy by 38.7% in the third quarter. Fifth Third Bancorp now owns 702 shares of the company’s stock worth $60,000 after acquiring an additional 196 shares in the last quarter.

U.S. Physical Therapy Stock Up 4.7%

Shares of U.S. Physical Therapy stock opened at $83.04 on Monday. The firm has a market cap of $1.26 billion, a PE ratio of 58.48, a P/E/G ratio of 2.08 and a beta of 1.30. The business’s 50 day simple moving average is $83.60 and its 200 day simple moving average is $82.45. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.20 and a current ratio of 1.01. U.S. Physical Therapy, Inc. has a 52-week low of $62.77 and a 52-week high of $93.50.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $0.67 earnings per share for the quarter, hitting the consensus estimate of $0.67. U.S. Physical Therapy had a net margin of 5.07% and a return on equity of 8.75%. The company had revenue of $202.73 million during the quarter, compared to analysts’ expectations of $200.10 million. During the same period last year, the business earned $0.51 EPS. The business’s quarterly revenue was up 12.3% on a year-over-year basis. On average, analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 10th. Investors of record on Friday, March 13th will be given a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a yield of 2.2%. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.45. The ex-dividend date of this dividend is Friday, March 13th. U.S. Physical Therapy’s payout ratio is 126.76%.

Wall Street Analyst Weigh In

USPH has been the topic of several recent analyst reports. Barrington Research reiterated an “outperform” rating and set a $103.00 price objective on shares of U.S. Physical Therapy in a report on Friday, February 20th. JPMorgan Chase & Co. dropped their target price on shares of U.S. Physical Therapy from $110.00 to $100.00 and set an “overweight” rating on the stock in a report on Monday, November 24th. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Monday, December 15th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of U.S. Physical Therapy in a report on Wednesday, January 21st. Four investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, U.S. Physical Therapy presently has an average rating of “Moderate Buy” and an average target price of $105.33.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.